Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance

Breast tumors generally consist of a diverse population of cells with varying gene expression profiles. Breast tumor heterogeneity is a major factor contributing to drug resistance, recurrence, and metastasis after chemotherapy. Antibody-drug conjugates (ADCs) are emerging chemotherapeutic agents wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamazaki, Chisato M., Yamaguchi, Aiko, Anami, Yasuaki, Xiong, Wei, Otani, Yoshihiro, Lee, Jangsoon, Ueno, Naoto T., Zhang, Ningyan, An, Zhiqiang, Tsuchikama, Kyoji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192907/
https://www.ncbi.nlm.nih.gov/pubmed/34112795
http://dx.doi.org/10.1038/s41467-021-23793-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192907/
https://www.ncbi.nlm.nih.gov/pubmed/34112795
http://dx.doi.org/10.1038/s41467-021-23793-7

Ejemplares similares